Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › VA › Norton › NPI 1326041716
Hospital

Norton Community Hospital, INC

Norton Community Hospital, INC was paid $8.22M by Medicaid between Jan 2018 and Feb 2021, across 233 billing codes. Its largest line is 99283, emergency room visit (moderate) — 14% of everything it billed.

33Billing provider infoNORTON COMMUNITY HOSPITAL, INC
NORTON, VA 24273
33aNPI1326041716assigned 05/31/2005
33bProvider typeGeneral Acute Care Hospital
28Total paid$8.22M
24GClaims359,439
24DCodes billed233
24AFirst – last monthJan 2018 – Feb 2021
Compared with peers

Next to other General Acute Care Hospital providers in Virginia

Rank by total paid#54 of 80
Median peer was paid$14.69M
This provider vs. median0.6×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$200K$400K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201899,889$1.81M
2019121,799$2.66M
2020120,883$3.22M
202116,868$535K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 14% 10,534 9,188 $1.14M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 13% 8,366 6,985 $1.03M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 12% 10,415 8,556 $1.01M
96361 Intravenous infusion, hydration; each additional hour 7.8% 3,562 2,721 $645K
74177 Computed tomography, abdomen and pelvis; with contrast material 6.9% 2,615 2,301 $569K
70450 Computed tomography, head or brain; without contrast material 4.3% 2,351 2,031 $355K
74176 Computed tomography, abdomen and pelvis; without contrast material 4.1% 1,882 1,609 $340K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete 2.9% 1,143 981 $241K
36415 Collection of venous blood by venipuncture 2.5% 25,598 18,476 $208K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 2.4% 3,991 903 $199K
99282 Emergency department visit for the evaluation and management, low to moderate severity 2.2% 1,629 1,471 $184K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour 1.8% 1,201 1,045 $146K
221 more codes
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 1.5% 4,539 $126K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress 1.5% 271 $126K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction 1.5% 2,258 $119K
80053 Comprehensive metabolic panel 1.4% 20,603 $115K
S0028 Injection, famotidine, 20 mg 1.3% 239 $109K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 1.1% 1,281 $92K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 220 $75K
71275 Computed tomographic angiography, chest, with contrast material <1% 368 $65K
72148 Magnetic resonance imaging, lumbar spine; without contrast material <1% 307 $50K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 507 $48K
77067 Screening mammography, bilateral, including computer-aided detection <1% 1,062 $48K
71046 Radiologic examination, chest; 2 views <1% 4,506 $43K
G0378 Hospital observation service, per hour <1% 1,516 $42K
87040 <1% 4,117 $39K
72125 Computed tomography, cervical spine; without contrast material <1% 842 $39K
99213 Doctor's office visit, returning patient (routine) <1% 280 $35K
93971 <1% 357 $33K
93017 <1% 305 $32K
87077 <1% 5,557 $31K
J3490 Unclassified drugs <1% 2,511 $31K
83880 <1% 2,590 $30K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 4,161 $30K
71250 <1% 455 $27K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 274 $26K
74018 <1% 1,540 $26K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 9,850 $24K
80048 Basic metabolic panel (calcium, ionized) <1% 4,493 $23K
84443 Thyroid stimulating hormone (TSH) <1% 5,877 $23K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material <1% 110 $20K
J7030 Infusion, normal saline solution , 1000 cc <1% 983 $19K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 21,661 $19K
59025 Fetal non-stress test <1% 135 $19K
84484 <1% 9,448 $17K
76536 <1% 200 $17K
73562 <1% 1,106 $16K
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 767 $16K
71045 Radiologic examination, chest; single view <1% 5,590 $15K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 1,018 $14K
76815 Ultrasound, pregnant uterus, real time with image documentation, limited <1% 213 $14K
83036 Hemoglobin; glycosylated (A1C) <1% 2,674 $13K
72100 <1% 965 $13K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 8,895 $13K
81001 <1% 7,477 $13K
99291 Critical care, evaluation and management of the critically ill patient, first 30-74 minutes <1% 63 $12K
80329 <1% 1,262 $12K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 357 $12K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 8,400 $11K
84439 <1% 2,859 $11K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 741 $9K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 1,045 $9K
84702 <1% 1,552 $9K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel <1% 420 $9K
96375 Therapeutic injection; each additional sequential IV push <1% 5,634 $9K
85027 <1% 3,278 $9K
83605 <1% 4,281 $9K
87088 <1% 3,574 $9K
80061 Lipid panel <1% 2,329 $8K
73610 <1% 750 $8K
81025 <1% 2,604 $8K
97162 <1% 229 $8K
73030 <1% 786 $8K
73630 <1% 1,060 $8K
80074 <1% 317 $7K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation <1% 89 $7K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 608 $7K
S0020 Injection, bupivicaine hydrochloride, 30 ml <1% 273 $6K
J7620 Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme <1% 589 $6K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 2,678 $6K
81003 <1% 5,538 $6K
J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg <1% 307 $6K
73130 <1% 662 $6K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 58 $5K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 76 $5K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 825 $5K
76641 <1% 68 $5K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 5,834 $4K
45378 Colonoscopy, flexible; diagnostic, including collection of specimen(s) <1% 13 $4K
80320 <1% 987 $4K
85379 <1% 534 $4K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 738 $3K
97014 <1% 133 $3K
83735 <1% 6,002 $3K
77002 <1% 13 $3K
82607 <1% 701 $3K
87070 <1% 875 $3K
87186 <1% 1,846 $3K
72131 <1% 136 $3K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 34 $3K
86850 <1% 378 $3K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 157 $3K
84480 <1% 129 $3K
12001 <1% 12 $3K
85610 <1% 7,757 $3K
90715 <1% 185 $3K
73110 <1% 268 $2K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 3,184 $2K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 414 $2K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 186 $2K
85730 <1% 5,647 $2K
84146 <1% 143 $2K
86901 <1% 1,191 $2K
73221 <1% 12 $2K
80076 <1% 611 $2K
82565 <1% 364 $2K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 12 $2K
86900 <1% 1,307 $2K
72040 <1% 58 $2K
83001 <1% 110 $2K
84481 <1% 113 $2K
73502 <1% 169 $2K
87086 Culture, bacterial; quantitative colony count, urine <1% 412 $2K
83690 <1% 4,945 $2K
96376 <1% 1,551 $2K
J7120 Ringers lactate infusion, up to 1000 cc <1% 20 $2K
76830 Ultrasound, transvaginal <1% 33 $1K
93225 <1% 41 $1K
82728 <1% 519 $1K
86140 <1% 976 $1K
93226 <1% 41 $1K
83655 <1% 106 $1K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 2,512 $1K
G0283 Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care <1% 68 $1K
86592 <1% 303 $1K
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 1,499 $1K
85018 <1% 353 $1K
76801 <1% 14 $1K
83002 <1% 118 $1K
86803 <1% 259 $1K
84703 <1% 1,980 $1K
74022 <1% 214 $988.11
J2543 Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) <1% 95 $975.66
83540 <1% 686 $950.03
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 3,193 $942.82
84466 <1% 554 $921.66
82570 <1% 319 $921.55
A9585 Injection, gadobutrol, 0.1 ml <1% 86 $896.41
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 190 $887.21
70486 <1% 25 $857.83
85652 <1% 1,060 $820.26
87807 <1% 820 $803.00
J3010 Injection, fentanyl citrate, 0.1 mg <1% 2,921 $791.30
76770 <1% 21 $766.38
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 158 $762.17
J1650 Injection, enoxaparin sodium, 10 mg <1% 250 $711.93
94729 <1% 32 $689.02
36600 <1% 484 $684.29
82950 <1% 104 $647.14
73080 <1% 116 $645.09
84100 <1% 962 $625.44
94664 <1% 65 $615.96
82150 <1% 925 $560.82
J1642 Injection, heparin sodium, (heparin lock flush), per 10 units <1% 485 $558.16
87147 <1% 437 $556.20
84144 <1% 44 $556.12
0296T <1% 32 $554.88
80050 General health panel <1% 13 $531.18
84403 <1% 43 $523.54
J0780 Injection, prochlorperazine, up to 10 mg <1% 557 $503.23
J7050 Infusion, normal saline solution, 250 cc <1% 103 $501.74
77066 Tomosynthesis, mammo <1% 13 $498.65
83615 <1% 784 $491.87
73590 <1% 91 $490.26
94726 <1% 31 $488.28
J2270 Injection, morphine sulfate, up to 10 mg <1% 1,891 $456.47
86762 <1% 94 $451.59
82140 <1% 586 $436.07
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen <1% 1,340 $407.56
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 346 $407.19
87081 <1% 339 $394.31
0011A <1% 51 $376.19
82803 <1% 782 $361.47
82330 <1% 266 $351.24
84550 <1% 260 $312.58
80055 <1% 119 $291.64
87653 <1% 12 $281.02
82043 <1% 125 $273.54
87210 <1% 327 $225.57
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 1,831 $221.26
87205 <1% 259 $177.72
A9500 Technetium tc-99m sestamibi, diagnostic, per study dose <1% 259 $175.72
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 1,829 $163.75
83550 <1% 41 $159.81
J3370 Injection, vancomycin hcl, 500 mg <1% 119 $154.82
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 1,187 $130.07
82550 <1% 169 $126.93
J2360 Injection, orphenadrine citrate, up to 60 mg <1% 253 $120.55
J1170 Injection, hydromorphone, up to 4 mg <1% 401 $119.64
86308 <1% 175 $112.72
G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed <1% 19 $107.59
J0690 Injection, cefazolin sodium, 500 mg <1% 925 $101.22
84156 <1% 33 $92.13
82784 <1% 12 $86.31
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 273 $85.89
84153 <1% 28 $70.39
S0164 Injection, pantoprazole sodium, 40 mg <1% 63 $70.34
94761 <1% 94 $60.13
J0171 Injection, adrenalin, epinephrine, 0.1 mg <1% 40 $57.21
87075 <1% 17 $49.66
88312 <1% 109 $43.49
J2060 Injection, lorazepam, 2 mg <1% 305 $38.46
J2704 Injection, propofol, 10 mg <1% 2,061 $36.10
87076 <1% 31 $23.92
J3480 Injection, potassium chloride, per 2 meq <1% 154 $19.89
J2550 Injection, promethazine hcl, up to 50 mg <1% 260 $19.01
C9113 Injection, pantoprazole sodium, per vial <1% 106 $10.52
J3475 Injection, magnesium sulfate, per 500 mg <1% 169 $7.39
82009 <1% 31 $4.94
73552 <1% 24 $4.63
J7510 Prednisolone oral, per 5 mg <1% 55 $3.72
J1644 Injection, heparin sodium, per 1000 units <1% 21 $2.16
J2710 Injection, neostigmine methylsulfate, up to 0.5 mg <1% 51 $1.97
J0692 Injection, cefepime hydrochloride, 500 mg <1% 14 $1.52
J1940 Injection, furosemide, up to 20 mg <1% 17 $1.47
A9270 Non-covered item or service <1% 537 $1.40
J1580 Injection, garamycin, gentamicin, up to 80 mg <1% 16 $1.17
J2785 Injection, regadenoson, 0.1 mg 0% 158 $0.00
72170 0% 32 $0.00
88304 0% 13 $0.00
73090 0% 13 $0.00
94760 0% 29 $0.00
93975 0% 25 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialKRUTAK, MARY (EVP/CFO)
Same official

Other billing entities under KRUTAK, MARY

Full network →
ProviderLocationPaid
Laughlin Memorial Hospital, INC.Greeneville, TN$1.86M
Community Home Care, INC.Norton, VA$346K
Dickenson Medical Associates a Department of Dickenson Community HospiClintwood, VA$174K
Mountain States Health AllianceMarion, VA$79K
Mountain States Health AllianceClintwood, VA$27K
Mountain States Health AllianceLebanon, VA$17K
Johnston Memorial Hospital, INCAbingdon, VA$5K
Wellmont Medical Associates, INC.Johnson City, TN$56.37

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.